October 24, 2014 8:11 PM ET

Biotechnology

Company Overview of IDUN Pharmaceuticals, Inc.

Company Overview

IDUN Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of human therapeutics to control apoptosis. The company’s products under Phase 2 and preclinical trials include drugs for liver disease, CNS diseases, inflammation, and cancer, as well as IDN-6556 for the treatment of liver diseases in patients infected with Hepatitis C virus. The company was founded in 1993 and is based in San Diego, California. As of July 30, 2010, IDUN Pharmaceuticals, Inc. operates as a subsidiary of Conatus Pharmaceuticals Inc.

9380 Judicial Drive

San Diego, CA 92121

United States

Founded in 1993

Phone:

858-623-1330

Fax:

858-623-2765

Key Executives for IDUN Pharmaceuticals, Inc.

Co-founder and Chairman of Scientific Advisory Board
Co-founder and Member of Scientific Advisory Board
Age: 56
Senior Medical Advisor
Senior Medical Advisor
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Differential Proteomics, Inc. United States
NeuroNascent, Inc. United States
Ginkgo BioWorks, Inc. United States
Bimini Technologies LLC United States
Nuon Therapeutics, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
February 13, 2014
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IDUN Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.